choriocarcinoma (Cancer)
Information
- Disease name
- choriocarcinoma
- Disease ID
- DOID:3594
- Description
- "A placenta cancer that has_material_basis_in trophoblastic cells." [url:https\://en.wikipedia.org/wiki/Choriocarcinoma]
Disease area statistics
Chromosome band
Gene symbol | Chromosome | Start | Stop | The number of variant |
---|---|---|---|---|
HLA-C | 6 | 31,268,749 | 31,272,092 | 4 |
MLH1 | 3 | 36,993,518 | 37,050,846 | 2 |
KMT2C | 7 | 152,134,925 | 152,436,003 | 2 |
TSC2 | 16 | 2,047,985 | 2,089,491 | 2 |
RAD51B | 14 | 67,819,779 | 68,611,565 | 2 |
HLA-B | 6 | 31,353,875 | 31,367,067 | 2 |
RNF43 | 17 | 58,353,676 | 58,417,533 | 2 |
CEBPA | 19 | 33,299,934 | 33,302,534 | 2 |
MSH2 | 2 | 47,403,156 | 47,483,223 | 2 |
ZRSR2 | X | 15,790,484 | 15,823,260 | 2 |
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02375204 | Active, not recruiting | Phase 3 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | August 5, 2015 | June 2024 |
NCT00190918 | Completed | Phase 2 | A Trial for Patients With Gestational Trophoblastic Disease | July 2006 | July 2007 |
NCT01535053 | Completed | Phase 3 | Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | June 18, 2012 | July 17, 2020 |
NCT02396511 | Completed | Phase 2 | TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma | January 2015 | December 2017 |
NCT05564026 | Recruiting | Molecular Epidemiology of Pediatric Germ Cell Tumors | April 12, 2023 | June 30, 2027 | |
NCT04562558 | Recruiting | N/A | Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | September 29, 2020 | December 2025 |
NCT04684368 | Recruiting | Phase 2 | A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT | July 13, 2021 | December 21, 2029 |
NCT02664961 | Terminated | Phase 2 | Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) | March 2016 | November 2018 |
NCT00294177 | Unknown status | Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma | August 2006 | July 2008 | |
NCT01267851 | Unknown status | Clinical Database and Biobank of Patients With Gynecologic Neoplasms | January 1, 2010 | December 30, 2020 |
- Disase is a (Disease Ontology)
- DOID:2021
- Cross Reference ID (Disease Ontology)
- GARD:6059
- Cross Reference ID (Disease Ontology)
- ICD10CM:C58
- Cross Reference ID (Disease Ontology)
- ICDO:9100/3
- Cross Reference ID (Disease Ontology)
- MESH:D002822
- Cross Reference ID (Disease Ontology)
- NCI:C2948
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:189444004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0008497
- Exact Synonym (Disease Ontology)
- Chorioepithelioma
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100768
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002822